A recent Swedish study on more than 5000 unselected breast cancer patients reported that the prevalence of pathogenic BRCA1/2 mutations was 1.8%; six in ten BRCA1/2 mutation carriers were not detected by selective clinical screening of individuals [69]. The gene discussed is BRCA1; the disease is breast carcinoma.